Participated · Series A · Jun 2025

Projectworks provides professional services automation and a project intelligence platform that connects users' ecosystems and aims to give time back to focus on billable work. The company supports more than 15,000 engineers, architects, software, and management consultants around the world. Led by CEO Mark Orttung, Projectworks focuses on product development and customer success for consulting firms. The company added $12M to its Series A in June 2025 and now has more than $20M in total funding. The new capital is intended to expand product development, go-to-market, and customer success teams. Projectworks is based in San Mateo, California. Projectworks offers a PSA platform used by around 500 customers to manage and optimise project delivery for professional services firms. The company has expanded rapidly across New Zealand, Australia, the United States, Canada, and the United Kingdom. Leadership includes founders Julian Clarke, Matthew Hayter, and Doug Taylor, with Mark Orttung as CEO. Projectworks recently completed a Series A that values the company at over NZD 100 million. The funding is earmarked to support global customer acquisition, increase R&D investment, and establish a product and engineering team in Silicon Valley. These moves are intended to accelerate the company’s expansion into the U.S. and other markets. Projectworks is a Wellington-based, cloud platform for managing professional services firms that integrates with accounting systems like Xero and CRMs like HubSpot. Launched in 2019, the SaaS product targets mid-sized consultancies in management, software, engineering and architecture, and estimates a total addressable market of more than US$100 billion with combined annual growth of 13.4%. The company reports 170% annual revenue growth and serves over 100 customers whose staff span 40 countries. Projectworks has won Xero Emerging App Partner of the Year (2020) and the Microsoft Emerge X competition, and was a 2021 Xero App Partner of the Year finalist. Leadership emphasizes a technical founding team and a product designed to eliminate multi-platform complexity for specialist consultancies. The company plans to use capital to hire developers in Wellington, expand global sales in Australia, the UK and the US, and invest in content marketing and digital advertising.

Participated · Equity · Sep 2023

Avasa is developing the Avasa Coupler, a category‑defining device that enables safe, fast and standardized reconnection of micro‑arteries used in reconstructive microsurgery. The company has reached design freeze and built pre‑production units that achieved 100% success in chronic animal studies. Founder and CEO Dr. Nandoun Abeysekera is a clinician‑bioengineer and Avasa reports strong clinical demand—89% of the 100+ microsurgeons interviewed expressed strong interest. Founded in 2018 and based in Auckland, New Zealand, Avasa is completing verification testing and recruiting commercial leadership to build its go‑to‑market strategy. The company intends to use the new capital to progress through FDA clearance and to launch commercially within the next 18 months. Avasa, led by CEO and founder Dr. Nandoun Abeysekera, is an Auckland, New Zealand-based medical device company focused on innovating surgical procedures through implantable devices. The company’s core product targets reconstructive microsurgery to help patients who have suffered debilitating disease and deformity. Avasa raised $1.55M in funding and intends to use the proceeds to expand operations. The announcement lists participation from both new and existing investors. Dr. Abeysekera expects the scope of the company’s device to expand into other surgical fields, including organ transplants, cardiothoracic surgery, and vascular surgery. The coverage was reported by FInSMEs on 14 September 2023.